Dovepress - Open Access to Scientific and Medical Research

12013

Orphan Drugs: Research and Reviews
About Dovepress

Open access peer-reviewed scientific and medical journals.
Open Access

Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Advocacy

Support Open Access and Dove Press
Reprints

Promotional Article Monitoring - further details
Favored Author Program

Real benefits for authors, including fast-track processing of papers.

Orphan Drugs: Research and Reviews

(33,802) Views

Editor in Chief Dr Lise Aagaard

2230-6161

Editorial
Medical treatment of rare diseases must be put on the agenda
Aagaard L
Orphan Drugs: Research and Reviews 2011, 1:1-2
23 September 2011

Call For Submissions
Submit Original Research Article, Review, Case Report, or Rapid Communication in Orphan Drugs: Research and Reviews

Favored Author Program

We offer real benefits to our authors, including fast-track processing of papers.
Award Nominations Open

Nominations are now open for International Journal of Nanomedicine (IJN) Early Career Scientist Award, International Journal of Nanomedicine (IJN) Distinguished Scientist Award
Call For Submissions

Submit Original Research Article, Review, Case Report, or Rapid Communication in Orphan Drugs: Research and Reviews
About Dovepress

Dove Medical Press Ltd is a privately held company specializing in the publication of Open Access peer-reviewed journals across the broad spectrum

Copyright© 2013 Dove Medical Press Ltd, All Rights Reserved.
The opinions expressed in all articles published here are those of the specific author(s), and do not necessarily reflect the views of Dove Medical Press Ltd or any of its employees.

Orphan Drugs: Research and Reviews

Orphan Drugs: Research and Reviews

(33,802) Views

Editor in Chief Dr Lise Aagaard

2230-6161

You may also be interested in the following related journals:

Favored Author Program

Award Nominations Open

Call For Submissions

About Dovepress